Comment from Advancing American Freedom Foundation

Summary: The Advancing American Freedom Foundation opposes the ACOG petition, arguing that the FDA should not lift Risk Evaluation and Mitigation Strategies (REMS) for mifepristone. They urge the FDA to reinstate stricter regulations, including in-person physician consultations, citing concerns over the drug's safety and the potential for serious adverse events.